川宁生物 (301301)
Yili Chuanning Biotechnology Co., Ltd.
K-Line Chart
No K-line data available
Company NameYili Chuanning Biotechnology Co., Ltd.
Listing Date2022-12-27
Issue Price5RMB
Registered Capital223008.510k RMB
Legal RepresentativeDeng Xuheng
Registered AddressNo. 1 Gongchen Road, Yining Park, Horgos Economic Development Zone, Ili Kazakh Autonomous Prefecture, Xinjiang, China
IndustryChemical Pharmaceuticals
Main BusinessPrimarily engaged in the R&D and industrialization of bio-fermentation technology.
Company ProfileYili Chuanning Biotechnology Co., Ltd. is primarily engaged in the research, development, and industrialization of bio-fermentation technology. Its current products mainly include Erythromycin Thiocyanate, Cephalosporin Intermediates (7-ACA, D7ACA, and 7-ADCA), Penicillin Intermediates (6-APA and Penicillin G Potassium Salt), and Crude Ursodeoxycholic Acid. The issuer is one of the enterprises with a relatively large scale of industrial application of bio-fermentation technology in China, and is one of the leading companies in the antibiotic intermediates field with a comprehensive product portfolio and relatively advanced production processes.
Since its establishment, the issuer has consistently focused on technological innovation in the field of bio-fermentation, particularly the innovation and improvement of fermentation production processes for antibiotic intermediates. It has continuously cultivated and expanded its efforts, striving to lead the industry's technological development. The issuer's innovations have earned numerous honors. It was selected for the Ministry of Industry and Information Technology's (MIIT) first batch of green manufacturing system demonstration list in 2017, becoming the first pharmaceutical enterprise in Xinjiang to be selected. The issuer was also included in the MIIT's Intelligent Manufacturing Comprehensive Standardization and New Model Application Project list. It was awarded the title of "National Advanced Collective for Light Industry Science and Technology Innovation during the 12th Five-Year Plan" in 2016. Simultaneously, it became the fourth batch of circular economy pilot enterprises in the Xinjiang Uygur Autonomous Region and was recognized as an Enterprise Technology Center by the Science and Technology Department of the Xinjiang Uygur Autonomous Region.
Stock Details
1. Key Indicators
- Total Shares(W): 223008.50
- Circulating A-Shares(W): 61778.24
- Earnings Per Share(RMB): 0.2700
- Net Assets Per Share(RMB): 3.5541
- Operating Revenue(W RMB): 343598.43
- Total Profit(W RMB): 75177.48
- Net Profit Attributable to Parent(W RMB): 61139.32
- Net Profit Growth Rate(%): -43.17
- Weighted Return on Equity(%): 7.6300
- Operating Cash Flow Per Share(RMB): 0.2560
- Undistributed Profit Per Share(RMB): 0.9287
- Capital Reserve Per Share(RMB): 1.4796
2. Main Business
The main business covers:
- Research, development and industrialization of bio-fermentation technology and synthetic biology products
3. Company Basic Information
- Company Name: Yili Chuannig Biotechnology Co., Ltd.
- Listing Date: 2022-12-27
- Industry: Pharmaceutical Manufacturing
- Address: No. 516, Almaty Village, Yining Park, Khorgos Economic Development Zone, Ili Prefecture, Xinjiang Uygur Autonomous Region
- Website: www.klcnsw.com
- Company Profile：On June 3, 2020, Chuanning Co., Ltd. held a shareholders' meeting and passed a resolution to convert the company into a joint stock company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Chengdu Kelun Ningbei Enterprise Management Partnership (Limited Partnership) | General Legal Person | 2803.70 | 4.54 |
| 2 | Ningbo Yixingshengzhi Enterprise Management Partnership (Limited Partnership) | General Legal Person | 2557.33 | 4.14 |
| 3 | E Fund ChiNext Board Exchange Traded Open End Index Securities Investment Fund | Fund | 1366.94 | 2.21 |
| 4 | Ningbo Huining Chiyuan Enterprise Management Partnership (Limited Partnership) | General Legal Person | 1181.38 | 1.91 |
| 5 | CSI 500 Exchange Traded Open End Index Securities Investment Fund | Fund | 973.25 | 1.58 |
| 6 | Ningbo Yihongjutou Enterprise Management Partnership (Limited Partnership) | General Legal Person | 889.38 | 1.44 |
| 7 | Ningbo Zhongju Ningcheng Enterprise Management Partnership (Limited Partnership) | General Legal Person | 842.79 | 1.36 |
| 8 | Ningbo Yisirong Enterprise Management Partnership (Limited Partnership) | General Legal Person | 813.46 | 1.32 |
| 9 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 597.61 | 0.97 |
| 10 | Rui Zhong Life Insurance Co., Ltd. - Proprietary Funds | Insurance | 440.00 | 0.71 |
5. Concept Sectors
- Artificial Intelligence
- Hepatitis Concept
- Grain Concept
- Synthetic Biology
- AI Medical
- Margin Trading & Securities Lending
- Insurance New Entry
- Shareholding Concentration
- ChiNext Index
- Small Cap Growth
- SZSE 300
- CNI Growth
- SZSE Growth
- ChiNext 300
- ChiNext Medicine
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information